Product
B7-H3 CAR T cells
1 clinical trial
16 indications
Indication
Pediatric Solid TumorIndication
OsteosarcomaIndication
RhabdomyosarcomaIndication
NeuroblastomaIndication
Ewing SarcomaIndication
Wilms tumorIndication
Adrenocortical CarcinomaIndication
Desmoplastic Small Round Cell TumorIndication
Germ Cell CancerIndication
Rhabdoid TumorIndication
Clear Cell SarcomaIndication
hepatoblastomaIndication
MelanomaIndication
cancerIndication
Malignant Peripheral Nerve Sheath TumorsIndication
Soft Tissue SarcomaClinical trial
B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)Status: Recruiting, Estimated PCD: 2026-03-01